DNA logo

DNA

Ginkgo Bioworks Holdings Inc. Class A

$8.98
-$0.58(-6.02%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$582.88M
Volume
767.03K
52W Range
$5.00 - $17.58
Target Price
$10.00

Latest News for DNA

Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
TipRanks Canadian Auto-Generated Newsdesk5 days agoJan 15, 2026

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) has shared an announcement. Medicenna reported updated clinical data for its lead IL-2 super agonist MD......

Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials
TipRanks Canadian Auto-Generated Newsdesk5 days agoJan 15, 2026

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) just unveiled an announcement. Medicenna Therapeutics outlined a potentially pivotal 2026 as it advance......

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA)
Catie Powers8 days agoJan 13, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Axsome Therapeutics (AXSM – Research Report), Vert......

Ginkgo Bioworks realigns leadership, shifts COO responsibilities
TipRanks Auto-Generated Newsdeska month agoDec 23, 2025

Ginkgo Bioworks Holdings ( ($DNA) ) has shared an announcement. On December 18, 2025, Ginkgo Bioworks announced that longtime co-founder and Chief ......

News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.

ABCD
1SymbolPriceChangeVol
2DNA$8.98-6.0%767.03K
3
4
5
6

Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.